What I see here is a stock that is trying to claw back up from bad press and relentless shorting. The business itself is growing, doing fine and has an impressive focus on its future. RXMD’s persistent driven goals will win out. I won’t deny the frustration for investors but this stock will be a winner in the end.
News 
Market Data 
Discover 
AI
